None listed
Conditions
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
a) have been receiving a daily dose of a benzodiazepine for a minimum continuous period of 3 months; and b) are on a stable maintenance dose of a benzodiazepine at the time of entry into the study (5-40 mg/day of diazepam or its equivalent).
Exclusion criteria
a) have a current diagnosis of a psychotic disorder;b) are diagnosed with a gross brain disorder;c) have concurrent alcohol or other non-benzodiazepine drug dependence; d) are in current receipt of any other psychological treatment; or e) are pregnant or nursing.